Blog Articles

Hysterectomy (removal of uterus) and, especially myomectomy (removal of fibroids) may be associated with significant blood loss.

Correct recognition of surgical anatomy is the most important factor that determines surgeon’s ability to perform any safe and effective operation.

Ovarian dermoid cyst (cystic teratoma) is a certain type of germ cell tumor. The vast majority (98%) of these tumors are benign (mature) and only 2% are malignant (immature).

One of the options for permanent sterilization is hysteroscopic intra-fallopian tube placement of two flexible coils made of a mixture of polyester fibers, nickel, titanium, platinum, silver-tin and stainless steel.

Hysterectomy, which means removal of the uterus (womb), should always be the last resort in surgical armamentarium. Some of the indications for hysterectomy include menorrhagia (prolonged and heavy menstrual flow) and symptomatic leiomyomata (fibroids).

Who is a candidate for Robotically assisted Laparoscopic Hysterectomy, Myomectomy, Excision of Endometriosis and Sacrocolpopexy?

Traditionally, patients have recovered in the hospital for several days after a major gynecological surgery such as hysterectomy, myomectomy and sacrocolpopexy...

Unfortunately, many women will undergo one (or more) major gynecological surgeries including hysterectomy (removal of the uterus), myomectomy (removal of fibroid tumors in the uterus), and sacrocolpopexy (repair of “fallen” pelvic organs).

Minimally invasive gynecologic (MIG) techniques have generated significant improvement in surgical outcomes.

Potential surgical blood loss should be considered and discussed by surgeons and patients before surgery.

Normally, endometrial (uterine lining) cells are present only in the uterine cavity. These cells are shedding once a month resulting in a menstrual period flow.

As I discussed in my November 2011 blog, laparoscopic and/or robotic (minimally invasive) surgery has multiple and significant advantages as compared to laparotomy (open incision) surgery.

Hysterectomy and/or Myomectomy should be the last resort treating symptomatic fibroids.

For women with uterine fibroid tumors, laparoscopic myomectomy provides an excellent option by allowing women to retain their uterus and recovery more quickly than with traditional surgery.